HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term effects of intratympanic methylprednisolone perfusion treatment on intractable Ménière's disease.

AbstractOBJECTIVE:
This study aimed to investigate the long-term efficacy of intratympanic methylprednisolone perfusion treatment for intractable Ménière's disease.
METHODS:
A retrospective analysis of 17 intractable Ménière's disease patients treated with intratympanic methylprednisolone perfusion was performed. Treatment efficacy was evaluated according to the American Academy of Otolaryngology-Head and Neck Surgery criteria. Short and long-term control or improvement rates were calculated after 6 and 24 months, respectively.
RESULTS:
Sixteen patients were followed for more than two years. Short- and long-term vertigo control rates were 94 per cent and 81 per cent, respectively; short- and long-term functional activity improvements were 94 per cent and 88 per cent, respectively. The pure tone average was 53 ± 14 dB before treatment, and 50 ± 16 dB at 6 months and 52 ± 20 dB at 24 months after intratympanic methylprednisolone perfusion. Tinnitus was controlled or improved in five patients over the two-year follow-up period.
CONCLUSION:
Intratympanic methylprednisolone perfusion can effectively control vertigo and improve functional activity in intractable Ménière's disease patients with good hearing preservation. It may therefore be a viable alternative treatment for intractable Ménière's disease.
AuthorsW She, L Lv, X Du, H Li, Y Dai, L Lu, X Ma, F Chen
JournalThe Journal of laryngology and otology (J Laryngol Otol) Vol. 129 Issue 3 Pg. 232-7 (Mar 2015) ISSN: 1748-5460 [Electronic] England
PMID25655232 (Publication Type: Journal Article)
Chemical References
  • Glucocorticoids
  • Methylprednisolone
Topics
  • Adult
  • Audiometry, Pure-Tone (methods)
  • Female
  • Glucocorticoids (administration & dosage, adverse effects)
  • Humans
  • Injection, Intratympanic
  • Male
  • Meniere Disease (drug therapy, physiopathology)
  • Methylprednisolone (administration & dosage, adverse effects)
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: